With life-threatening food allergies on the rise, drug companies ramp up new approaches
date:Sep 28, 2018
with some skin reactions where the patch adheres as the main side effects.

Skorney says the choice between Aimmune's and DBV's treatments may come down to efficacy versus tolerability.

When we talk to physicians and families, there's this gravitation toward Viaskin just in terms of: this is so easy, you just put it on your kid and don't have to worry too much; you're not going through the cumbersome and sometimes intolerable step-up process that Aimmune's treatment requires, Skorney explained.
12/18 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/19 03:45